Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
This is a case report of a patient with allergy to the rapid acting insulins and rapid acting analogs. Before trying insulin desensitization the treatment was changed to a basal-bolus regimen with glargine and glulisine with no signs of insulin allergy during the months after the start of the treatment.
Mollar-Puchades
M A
MA
Department of Endocrinology, Specialty Care Center Jaume I, Castellon de la Plana, Spain. mimopu@comv.es
Villanueva
I Lafuente
IL
D000368:Aged; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use*; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000276:immunology / Q000627:therapeutic use; D061267:Insulin Aspart; D007336:Insulin, Isophane / Q000009:adverse effects / Q000276:immunology; D008297:Male
D007004:Hypoglycemic Agents; D007328:Insulin; D007336:Insulin, Isophane; C479079:insulin glulisine; D061267:Insulin Aspart